Chemical Name: 2,2'-(((3aR,3a'R,4S,4'S,6S,6aS,6'S,6a'S)-((5-amino-2-(propylthio)pyrimidine-4,6-diyl)bis(azanediyl))bis(2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxole-6,4-diyl))bis(oxy))bis(ethan-1-ol)
Smiles: CC1(C)O[C@@H]2[C@@H](OCCO)C[C@H](NC3=C(C(N[C@H]4C[C@H](OCCO)[C@@H]5[C@H]4OC(C)(C)O5)=NC(SCCC)=N3)N)[C@@H]2O1
Inchi: InChI=1S/C24H35Cl2N7O4S2/c1-5-9-38-22-30-18(25)14(27)20(32-22)29-12-11-13(17-16(12)36-24(3,4)37-17)34-7-8-35-21-15(28)19(26)31-23(33-21)39-10-6-2/h12-13,16-17H,5-11,27-28H2,1-4H3,(H,29,30,32)/t12-,13-,16+,17-/m1/s1
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42